United States · 
Who invested in Synnovation Therapeutics?
Synnovation Therapeutics's investors include Cormorant Asset Management and Lilly Asia Ventures.
United States · Series A startup
Who invested in Synnovation Therapeutics
Funding summaryUpdated 26 Oct 2026
$102Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $102MDec 2023
- Investors
- 2
The rounds
- Dec 2023Series A$102M
Source recordedSEC filing: $70M sold, first sale Dec 2023
Founders and team
From the SEC filings it signed: 2 on the team.
- Liangxing WuExecutive Officer, Directori
- Wenqing YaoExecutive Officer, Directori
On the board, as filediReid HuberTing Feng
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Synnovation Therapeutics
How much has Synnovation Therapeutics raised?
Synnovation Therapeutics has raised $102M across 1 round since 2023.
When did Synnovation Therapeutics last raise?
Synnovation Therapeutics's most recent round was a Series A of $102M in Dec 2023.
What was Synnovation Therapeutics's biggest round?
Its most recent round, $102M in Dec 2023, is also its largest on record.
Who backed Synnovation Therapeutics first?
Synnovation Therapeutics's first round on record, in Dec 2023, was backed by Cormorant Asset Management and Lilly Asia Ventures.
What stage is Synnovation Therapeutics at?
Synnovation Therapeutics's latest named round is a Series A, in Dec 2023.
Where is Synnovation Therapeutics based?
Synnovation Therapeutics is based in the United States.
Companies like Synnovation Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.